These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 24822191)

  • 1. Immune responses in Parkinson's disease: interplay between central and peripheral immune systems.
    Su X; Federoff HJ
    Biomed Res Int; 2014; 2014():275178. PubMed ID: 24822191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on immunity and inflammation in Parkinson disease pathology.
    Joshi N; Singh S
    J Neurosci Res; 2018 Mar; 96(3):379-390. PubMed ID: 29072332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of inflammation in sporadic and familial Parkinson's disease.
    Deleidi M; Gasser T
    Cell Mol Life Sci; 2013 Nov; 70(22):4259-73. PubMed ID: 23665870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of innate and adaptive immunity in Parkinson's disease.
    Kannarkat GT; Boss JM; Tansey MG
    J Parkinsons Dis; 2013; 3(4):493-514. PubMed ID: 24275605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson's Disease.
    Saponjic J; Mejías R; Nikolovski N; Dragic M; Canak A; Papoutsopoulou S; Gürsoy-Özdemir Y; Fladmark KE; Ntavaroukas P; Bayar Muluk N; Zeljkovic Jovanovic M; Fontán-Lozano Á; Comi C; Marino F
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson's Disease.
    Kustrimovic N; Marino F; Cosentino M
    Curr Med Chem; 2019; 26(20):3719-3753. PubMed ID: 30306855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of innate immunity and inflammation in Parkinson´s disease.
    Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
    Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of inflammatory system involvement in Parkinson's disease.
    Chao Y; Wong SC; Tan EK
    Biomed Res Int; 2014; 2014():308654. PubMed ID: 25050341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson disease and the immune system - associations, mechanisms and therapeutics.
    Tan EK; Chao YX; West A; Chan LL; Poewe W; Jankovic J
    Nat Rev Neurol; 2020 Jun; 16(6):303-318. PubMed ID: 32332985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease.
    Contaldi E; Magistrelli L; Comi C
    Handb Clin Neurol; 2023; 193():67-93. PubMed ID: 36803824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Metabolites Mirror Altered Gut Microbiota Composition in Patients with Parkinson's Disease.
    van Kessel SP; El Aidy S
    J Parkinsons Dis; 2019; 9(s2):S359-S370. PubMed ID: 31609701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenetic Determinants of Parkinson's Disease Etiology.
    Kung PJ; Elsayed I; Reyes-Pérez P; Bandres-Ciga S
    J Parkinsons Dis; 2022; 12(s1):S13-S27. PubMed ID: 35367971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia in Parkinson's Disease.
    Ho MS
    Adv Exp Med Biol; 2019; 1175():335-353. PubMed ID: 31583594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M1 and M2 immune activation in Parkinson's Disease: Foe and ally?
    Moehle MS; West AB
    Neuroscience; 2015 Aug; 302():59-73. PubMed ID: 25463515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and adaptive immune responses in Parkinson's disease.
    Schonhoff AM; Williams GP; Wallen ZD; Standaert DG; Harms AS
    Prog Brain Res; 2020; 252():169-216. PubMed ID: 32247364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolipids in Parkinson's disease: beyond neuronal function.
    Spanos F; Deleidi M
    FEBS Open Bio; 2023 Sep; 13(9):1558-1579. PubMed ID: 37219461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.
    Collins LM; Toulouse A; Connor TJ; Nolan YM
    Neuropharmacology; 2012 Jun; 62(7):2154-68. PubMed ID: 22361232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.
    Tansey MG; McCoy MK; Frank-Cannon TC
    Exp Neurol; 2007 Nov; 208(1):1-25. PubMed ID: 17720159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inflammatory pathomechanism for Parkinson's disease?
    Wersinger C; Sidhu A
    Curr Med Chem; 2006; 13(5):591-602. PubMed ID: 16515523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression and cognitive impairment in Parkinson's disease: a role for inflammation and immunomodulation?
    Pessoa Rocha N; Reis HJ; Vanden Berghe P; Cirillo C
    Neuroimmunomodulation; 2014; 21(2-3):88-94. PubMed ID: 24557040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.